1. body mass index
Conditions
Interventions
1. Vegan dietary intake is at least 5 years
2. Female with age 55 years and over
3. Do not take antibiotics, probiotics, vitamin D and calcium for more than 3 months
4. Do not drink alcohol and smoke
BMI is lower than 25.
6. Healthy (Do not have chronic diseases related to the gastrointestinal tract and Metabolic Syndrome e.g., obesity, diabetes (types 1 and 2), high blood pressure, fatty liver d
s disease, Ulcerative colitis, Bacterial overgrowth syndrome, Celiac disease and Irritable Bowel Syndrome).
7. People who do not have Haemophilia or Hemorrhagic disease, liver disease, heart disease,
BMI is lower than 25.
5. Healthy (Do not have chronic diseases related to the gastrointestinal tract and Metabolic Syndrome e.g., obesity, diabetes (types 1 and 2), high blood pressure, fatty liver d
s disease, Ulcerative colitis, Bacterial overgrowth syndrome, Celiac disease and Irritable Bowel Syndrome).
6. People who do not have Haemophilia or Hemorrhagic disease, liver disease, heart disease,
Screening,Screening
vegan participants,omnivore participants
Sponsors
Faculty of Science, Chulalongkorn University
Eligibility
Sex/Gender
Female
Age
55 Years to No maximum
Inclusion criteria
Inclusion criteria: For 34 vegans 1. Vegan diet intake is at least 5 years 2. Female with age 55 years and over 3. Do not take antibiotics, probiotics, vitamin D and calcium for more than 3 months 4. Do not drink alcohol and smoke regularly. 5. body mass index; BMI is lower than 25. 6. Healthy (Do not have chronic diseases related to the gastrointestinal tract and Metabolic Syndrome e.g., obesity, diabetes (types 1 and 2), high blood pressure, fatty liver disease, cardiovascular disease, Crohn's disease, Ulcerative colitis, Bacterial overgrowth syndrome, Celiac disease and Irritable Bowel Syndrome). 7. People who do not have Haemophilia or Hemorrhagic disease, liver disease, heart disease, or people who must not receive medicine which affects on blood clotting such as warfarin, rivaroxaban Dabigatran, Apixaban, Edoxaban and Heparin. For 34 Omnivores 1. Female with age 55 years and over 2. Do not take antibiotics, probiotics, vitamin D and calcium for more than 3 months 3. Do not drink alcohol and smoke regularly. 4. body mass index; BMI is lower than 25. 5. Healthy (Do not have chronic diseases related to the gastrointestinal tract and Metabolic Syndrome e.g., obesity, diabetes (types 1 and 2), high blood pressure, fatty liver disease, cardiovascular disease, Crohn's disease, Ulcerative colitis, Bacterial overgrowth syndrome, Celiac disease and Irritable Bowel Syndrome). 6. People who do not have Haemophilia or Hemorrhagic disease, liver disease, heart disease, or people who must not receive medicine which affects on blood clotting such as warfarin, rivaroxaban Dabigatran, Apixaban, Edoxaban and Heparin.
Exclusion criteria
Exclusion criteria: 1. Absent 2. Have diarrhea or have a disease related to the gastrointestinal tract during proceeding with collecting data and samples
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gut microbiota at 12 months after sample collection Measure in stool sample,Metabolites profile at 12 months after sample collection Measure in blood and urine,Osteoporosis risk (bone mineral density) at 3 months after sample collection DEXA scan,Information on food consumed at 12 months after sample collection Questionnaires (Physical activity, TASTE-26, Dietary recall 24 h) | — |
Secondary
| Measure | Time frame |
|---|---|
| The the relationship patterns between gut microbiota and metabolites at 12 months after sample collection Bioinformatic | — |
Countries
Thailand
Contacts
Public ContactNatthanan Buranavanitvong
Chulalongkorn University
Outcome results
None listed